ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Omvoh 100 mg + 200 mg, solution injectable en stylo prérempli - 1 +
68952002 Eli Lilly (Suisse) SA
Omvoh 100 mg + 200 mg, solution injectable en stylo prérempli30.11.2023
  20.06.2025
Interleukin Inhibitors (L04AC) 
WHO-DDD29.11.2028
07.15.1 +
07.15. 
B  
No 
IP 
PR  
k.A.PR
  
7680689520025Biotechnologika
  
Composition
II) 200 mg: mirikizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 2.2974 mg. I) 100 mg: mirikizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.1487 mg.
Packungsbestandteile
II
Injection solution in prefilled syringe
 
 
Active AgentDose
Mirikizumabum200mg / 2ml
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Mannitol
Sodium Chloride
Polysorbatum 80
I
Injection solution in prefilled syringe
 
 
Active AgentDose
Mirikizumabum100 mg/ml
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Mannitol
Sodium Chloride
Polysorbatum 80
Source
Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home